Poonam Kumari

Poonam Kumari

Auto-generated profile, based on publicly available information

Poonam Kumari

International Centre for Genetic Engineering and Biotechnology New Delhi India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Structural Biology
Verified
Journal Article
Closed access
PKPoonam Kumari
Poonam Kumari
Mrigya BabutaMrigya Babuta
Mrigya Babuta
ABAlok Bhattacharya
Alok Bhattacharya
SGSamudrala Gourinath
Samudrala Gourinath


17 June 2024 in ACS Omega
Verified
Journal Article
Open access
PKPoonam Kumari
Poonam Kumari
PAPrakhar Agrawal
Prakhar Agrawal
PUPreeti Umarao
Preeti Umarao
VRVijayan Ramachandran
Vijayan Ramachandran
SGSamudrala Gourinath
Samudrala Gourinath
Amoebiasis, a widespread disease caused by the protozoan parasite Entamoeba histolytica, poses challenges due to the adverse effects of existing antiamoebic drugs and rising drug resistance. Novel targeted drugs are in need of the hour to combat the prevalence of this disease. Given the significance of cysteine for Entamoeba survival, the rate-determining step in the serine (the sole substrate of cysteine synthesis) biosynthetic pathway, i.e., the conversion of 3-phosphoserine to l-serine catalyzed by phosphoserine phosphatase (PSP), emerges as a promising drug target. Our previous study unveils the essential role of EhPSP in amoebas' survival, particularly under oxidative stress, by increasing cysteine production. The study also revealed that EhPSP differs significantly from its human counterpart, both structurally and biochemically, highlighting its potential as a viable target for developing new antiamoebic drugs. In the present study, employing in silico screening of vast natural and synthetic small chemical compound libraries, we identified 21 potential EhPSP inhibitor molecules. Out of the 21 compounds examined, only five could inhibit the catalytic activity of EhPSP. The inhibition capability of these five compounds was subsequently validated by in silico binding free energy calculations, SPR-based real-time binding studies, and molecular simulations to assess the stability of the EhPSP-inhibitor complexes. By identifying the five potential inhibitors that can target cysteine synthesis via EhPSP, our findings establish EhPSP as a drug candidate that can serve as a foundation for antiamoebic drug research.

1 January 2020 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
PKPoonam Kumari
Poonam Kumari
DIDanish Idrees
Danish Idrees
PRPragyan Parimita Rath
Pragyan Parimita Rath
RVRamachandran Vijayan
Ramachandran Vijayan
SGSamudrala Gourinath
Samudrala Gourinath

4 July 2025 in The FEBS Journal
Verified
Journal Article
Closed access
PKPoonam Kumari
Poonam Kumari
AGAvinash Kumar Gautam
Avinash Kumar Gautam
MIMuzahidul Islam
Muzahidul Islam
IJIqbal Taliy Junaid
Iqbal Taliy Junaid
ZKZainab Khan
Zainab Khan
PMPawan Malhotra
Pawan Malhotra